ULORIC® Linked to Cardiovascular Deaths
According to healthycanadians.gc.ca, a post-market clinical study of the medication ULORIC®(febuxostat)indicates that there is an increased risk of cardiovascular (CV) fatal outcomes in patients with gout who have a history [...]